<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2009v1.4">
  <ReturnHeader binaryAttachmentCount="0">
    <Timestamp>2010-09-01T21:55:15-05:00</Timestamp>
    <TaxPeriodEndDate>2010-03-31</TaxPeriodEndDate>
    <PreparerFirm>
      <PreparerFirmBusinessName>
        <BusinessNameLine1>WINDES &amp; MCCLAUGHRY ACCT CORP</BusinessNameLine1>
      </PreparerFirmBusinessName>
      <PreparerFirmUSAddress>
        <AddressLine1>PO BOX 87</AddressLine1>
        <City>LONG BEACH</City>
        <State>CA</State>
        <ZIPCode>90801</ZIPCode>
      </PreparerFirmUSAddress>
    </PreparerFirm>
    <ReturnType>990</ReturnType>
    <TaxPeriodBeginDate>2009-04-01</TaxPeriodBeginDate>
    <Filer>
      <EIN>956043953</EIN>
      <Name>
        <BusinessNameLine1>ARTHRITIS NATIONAL RESEARCH FOUNDATION</BusinessNameLine1>
      </Name>
      <NameControl>ARTH</NameControl>
      <Phone>5624376808</Phone>
      <USAddress>
        <AddressLine1>200 OCEANGATE No 830</AddressLine1>
        <City>LONG BEACH</City>
        <State>CA</State>
        <ZIPCode>90802</ZIPCode>
      </USAddress>
    </Filer>
    <Officer>
      <Name>HELENE BELISLE</Name>
      <Title>EXECUTIVE DIRECTOR</Title>
      <Phone>5624376808</Phone>
      <DateSigned>2010-08-31</DateSigned>
      <AuthorizeThirdParty>1</AuthorizeThirdParty>
    </Officer>
    <Preparer>
      <Phone>5624351191</Phone>
    </Preparer>
    <TaxYear>2009</TaxYear>
    <BuildTS>2016-02-24 21:20:13Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCount="7">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <NameOfPrincipalOfficerPerson>HELENE BELISLE</NameOfPrincipalOfficerPerson>
      <AddressPrincipalOfficerUS>
        <AddressLine1>200 OCEANGATE 830</AddressLine1>
        <City>LONG BEACH</City>
        <State>CA</State>
        <ZIPCode>90802</ZIPCode>
      </AddressPrincipalOfficerUS>
      <GrossReceipts>6974306</GrossReceipts>
      <GroupReturnForAffiliates>0</GroupReturnForAffiliates>
      <Organization501c typeOf501cOrganization="3">X</Organization501c>
      <WebSite>WWW.CUREARTHRITIS.ORG</WebSite>
      <TypeOfOrganizationCorporation>X</TypeOfOrganizationCorporation>
      <YearFormation>1952</YearFormation>
      <StateLegalDomicile>CA</StateLegalDomicile>
      <ActivityOrMissionDescription>Provide financial support for: prevention, treatment &amp; cure of arthritis &amp; other rheumatic diseases</ActivityOrMissionDescription>
      <NbrVotingMembersGoverningBody>14</NbrVotingMembersGoverningBody>
      <NbrIndependentVotingMembers>14</NbrIndependentVotingMembers>
      <TotalNbrEmployees>3</TotalNbrEmployees>
      <TotalNbrVolunteers>30</TotalNbrVolunteers>
      <TotalGrossUBI>0</TotalGrossUBI>
      <NetUnrelatedBusinessTxblIncome>0</NetUnrelatedBusinessTxblIncome>
      <ContributionsGrantsPriorYear>2042938</ContributionsGrantsPriorYear>
      <ContributionsGrantsCurrentYear>3040909</ContributionsGrantsCurrentYear>
      <ProgramServiceRevenueCY>0</ProgramServiceRevenueCY>
      <InvestmentIncomePriorYear>7009</InvestmentIncomePriorYear>
      <InvestmentIncomeCurrentYear>151307</InvestmentIncomeCurrentYear>
      <OtherRevenuePriorYear>8275</OtherRevenuePriorYear>
      <OtherRevenueCurrentYear>-2200</OtherRevenueCurrentYear>
      <TotalRevenuePriorYear>2058222</TotalRevenuePriorYear>
      <TotalRevenueCurrentYear>3190016</TotalRevenueCurrentYear>
      <GrantsAndSimilarAmntsPriorYear>899500</GrantsAndSimilarAmntsPriorYear>
      <GrantsAndSimilarAmntsCY>921000</GrantsAndSimilarAmntsCY>
      <BenefitsPaidToMembersCY>0</BenefitsPaidToMembersCY>
      <SalariesEtcPriorYear>115012</SalariesEtcPriorYear>
      <SalariesEtcCurrentYear>121147</SalariesEtcCurrentYear>
      <TotalProfFundrsngExpCY>0</TotalProfFundrsngExpCY>
      <TotalFundrsngExpCurrentYear>20201</TotalFundrsngExpCurrentYear>
      <OtherExpensePriorYear>172781</OtherExpensePriorYear>
      <OtherExpensesCurrentYear>190026</OtherExpensesCurrentYear>
      <TotalExpensesPriorYear>1187293</TotalExpensesPriorYear>
      <TotalExpensesCurrentYear>1232173</TotalExpensesCurrentYear>
      <RevenuesLessExpensesPriorYear>870929</RevenuesLessExpensesPriorYear>
      <RevenuesLessExpensesCY>1957843</RevenuesLessExpensesCY>
      <TotalAssetsBOY>3139388</TotalAssetsBOY>
      <TotalAssetsEOY>5664196</TotalAssetsEOY>
      <TotalLiabilitiesBOY>3841</TotalLiabilitiesBOY>
      <TotalLiabilitiesEOY>4846</TotalLiabilitiesEOY>
      <NetAssetsOrFundBalancesBOY>3135547</NetAssetsOrFundBalancesBOY>
      <NetAssetsOrFundBalancesEOY>5659350</NetAssetsOrFundBalancesEOY>
      <MissionDescription>To fund promising young scientists at the beginning of their research careers to pursue cutting-edge projects for the treatment, cure, and the eventual end to the suffering of over 46 million Americans with arthritis and its related diseases.</MissionDescription>
      <SignificantNewProgramServices>0</SignificantNewProgramServices>
      <SignificantChange>0</SignificantChange>
      <Expense>1002066</Expense>
      <Grants>921000</Grants>
      <Description>Medical Research Grants awarded based on grant proposals received from outside investigators working at independent, unaffiliated research facilities and universities and reviewed by independent Scientific Advisory Board and Scientific Review Committee. Also includes grants for professional meeting support related to research funded.</Description>
      <Activity2>
        <Expense>95504</Expense>
        <Description>Program service education to raise awareness to members of the general public and in the medical profession regarding the need for arthritis research for a cure.</Description>
      </Activity2>
      <TotalProgramServiceExpense>1097570</TotalProgramServiceExpense>
      <DescribedIn501C3 referenceDocumentId="RetDoc1039100001">1</DescribedIn501C3>
      <ScheduleBRequired referenceDocumentId="RetDoc1234500001">1</ScheduleBRequired>
      <PoliticalActivities>0</PoliticalActivities>
      <LobbyingActivities>0</LobbyingActivities>
      <DonorAdvisedFunds referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFunds>
      <ConservationEasements referenceDocumentId="RetDoc1040000001">0</ConservationEasements>
      <CollectionsOfArt referenceDocumentId="RetDoc1040000001">0</CollectionsOfArt>
      <CreditCounseling referenceDocumentId="RetDoc1040000001">0</CreditCounseling>
      <TermOrPermanentEndowments referenceDocumentId="RetDoc1040000001">1</TermOrPermanentEndowments>
      <BalanceSheetAmountsReported referenceDocumentId="RetDoc1040000001">1</BalanceSheetAmountsReported>
      <IndependentAuditFinancialStmt referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinancialStmt>
      <ConsolidatedAuditFinancialStmt referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinancialStmt>
      <School>0</School>
      <ForeignOffice>0</ForeignOffice>
      <ForeignActivities>0</ForeignActivities>
      <MoreThan5000KToOrganizations>0</MoreThan5000KToOrganizations>
      <MoreThan5000KToIndividuals>0</MoreThan5000KToIndividuals>
      <ProfessionalFundraising>0</ProfessionalFundraising>
      <FundraisingActivities>0</FundraisingActivities>
      <Gaming>0</Gaming>
      <Hospital>0</Hospital>
      <GrantsToOrganizations referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizations>
      <GrantsToIndividuals referenceDocumentId="RetDoc1041900001">0</GrantsToIndividuals>
      <ScheduleJRequired>0</ScheduleJRequired>
      <TaxExemptBonds>0</TaxExemptBonds>
      <ExcessBenefitTransaction>0</ExcessBenefitTransaction>
      <PriorExcessBenefitTransaction>0</PriorExcessBenefitTransaction>
      <LoanToOfficerOrDQP>0</LoanToOfficerOrDQP>
      <GrantToRelatedPerson>0</GrantToRelatedPerson>
      <BsnssRltnshpWithOrganization>0</BsnssRltnshpWithOrganization>
      <BsnssRltnshpThruFamilyMember>0</BsnssRltnshpThruFamilyMember>
      <OfficerEntityWithBsnssRltnshp>0</OfficerEntityWithBsnssRltnshp>
      <DeductibleNonCashContributions referenceDocumentId="RetDoc1042900001">1</DeductibleNonCashContributions>
      <DeductibleContributionsOfArt referenceDocumentId="RetDoc1042900001">0</DeductibleContributionsOfArt>
      <Terminated>0</Terminated>
      <PartialLiquidation>0</PartialLiquidation>
      <DisregardedEntity>0</DisregardedEntity>
      <RelatedEntity>0</RelatedEntity>
      <RelatedOrgControlledEntity>0</RelatedOrgControlledEntity>
      <TransfersToExemptNonChrtblOrg>0</TransfersToExemptNonChrtblOrg>
      <ActivitiesConductedPartnership>0</ActivitiesConductedPartnership>
      <ScheduleORequired>1</ScheduleORequired>
      <NumberFormsTransmittedWith1096>0</NumberFormsTransmittedWith1096>
      <NumberW2GIncluded>0</NumberW2GIncluded>
      <ComplianceWithBackupWitholding>1</ComplianceWithBackupWitholding>
      <NumberOfEmployees>3</NumberOfEmployees>
      <EmploymentTaxReturnsFiled>1</EmploymentTaxReturnsFiled>
      <UnrelatedBusinessIncome>0</UnrelatedBusinessIncome>
      <ForeignFinancialAccount>0</ForeignFinancialAccount>
      <ProhibitedTaxShelterTrans>0</ProhibitedTaxShelterTrans>
      <TaxablePartyNotification>0</TaxablePartyNotification>
      <NonDeductibleContributions>0</NonDeductibleContributions>
      <QuidProQuoContributions>0</QuidProQuoContributions>
      <Form8282PropertyDisposedOf>0</Form8282PropertyDisposedOf>
      <NbrVotingGoverningBodyMembers>14</NbrVotingGoverningBodyMembers>
      <NumberIndependentVotingMembers>14</NumberIndependentVotingMembers>
      <FamilyOrBusinessRelationship>0</FamilyOrBusinessRelationship>
      <DelegationOfManagementDuties>0</DelegationOfManagementDuties>
      <ChangesToOrganizingDocs>0</ChangesToOrganizingDocs>
      <MaterialDiversionOrMisuse>0</MaterialDiversionOrMisuse>
      <MembersOrStockholders>0</MembersOrStockholders>
      <ElectionOfBoardMembers>0</ElectionOfBoardMembers>
      <DecisionsSubjectToApproval>0</DecisionsSubjectToApproval>
      <MinutesOfGoverningBody>1</MinutesOfGoverningBody>
      <MinutesOfCommittees>1</MinutesOfCommittees>
      <OfficerMailingAddress>0</OfficerMailingAddress>
      <LocalChapters>0</LocalChapters>
      <Form990ProvidedToGoverningBody>1</Form990ProvidedToGoverningBody>
      <ConflictOfInterestPolicy>1</ConflictOfInterestPolicy>
      <AnnualDisclosureCoveredPersons>1</AnnualDisclosureCoveredPersons>
      <RegularMonitoringEnforcement>1</RegularMonitoringEnforcement>
      <WhistleblowerPolicy>0</WhistleblowerPolicy>
      <DocumentRetentionPolicy>0</DocumentRetentionPolicy>
      <CompensationProcessCEO>1</CompensationProcessCEO>
      <CompensationProcessOther>1</CompensationProcessOther>
      <InvestmentInJointVenture>0</InvestmentInJointVenture>
      <StatesWhereCopyOfReturnIsFiled>CA</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>AZ</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>UT</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>VA</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>CT</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>FL</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>WA</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>IL</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>NJ</StatesWhereCopyOfReturnIsFiled>
      <UponRequest>X</UponRequest>
      <TheBooksAreInCareOf>
        <NameBusiness>
          <BusinessNameLine1>HELENE BELISLE</BusinessNameLine1>
        </NameBusiness>
        <TelephoneNumber>5624376808</TelephoneNumber>
        <AddressUS>
          <AddressLine1>200 OCEANGATE NO 830</AddressLine1>
          <City>LONG BEACH</City>
          <State>CA</State>
          <ZIPCode>90802</ZIPCode>
        </AddressUS>
      </TheBooksAreInCareOf>
      <Form990PartVIISectionA>
        <NamePerson>JAMES ROSE PHARMD</NamePerson>
        <Title>PRESIDENT</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Chuck Turner</NamePerson>
        <Title>Vice President</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Mark Schulten</NamePerson>
        <Title>Scretary-Treasurer</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Kevin Donohue</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Kathryn S Ferris</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Scott Green</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Gale A Granger PhD</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Nolan Harrison III</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Marti Krupin</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Britt L Meyer</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Lynn E Moyer ESQ</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Kathleen J Tepley</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Matt Walker</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Carl F Ware</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Helene Belisle</NamePerson>
        <Title>Executive Director</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>91452</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <TotalReportableCompFromOrg>91452</TotalReportableCompFromOrg>
      <TotalReportableCompFrmRltdOrgs>0</TotalReportableCompFrmRltdOrgs>
      <TotalOtherCompensation>0</TotalOtherCompensation>
      <NumberIndividualsGT100K>0</NumberIndividualsGT100K>
      <FormersListed>0</FormersListed>
      <TotalCompGT150K>0</TotalCompGT150K>
      <CompensationFromOtherSources>0</CompensationFromOtherSources>
      <NumberOfContractorsGT100K>0</NumberOfContractorsGT100K>
      <FederatedCampaigns>280332</FederatedCampaigns>
      <AllOtherContributions>2760577</AllOtherContributions>
      <NoncashContributions>264872</NoncashContributions>
      <TotalContributions>3040909</TotalContributions>
      <InvestmentIncome>
        <TotalRevenueColumn>67246</TotalRevenueColumn>
        <ExclusionAmount>67246</ExclusionAmount>
      </InvestmentIncome>
      <GrossAmountSalesAssets>
        <Securities>3851216</Securities>
      </GrossAmountSalesAssets>
      <LessCostOthBasisSalesExpenses>
        <Securities>3767155</Securities>
      </LessCostOthBasisSalesExpenses>
      <GainOrLoss>
        <Securities>84061</Securities>
      </GainOrLoss>
      <NetGainOrLossInvestments>
        <TotalRevenueColumn>84061</TotalRevenueColumn>
        <ExclusionAmount>84061</ExclusionAmount>
      </NetGainOrLossInvestments>
      <GrossIncomeFundraisingEvents>14935</GrossIncomeFundraisingEvents>
      <FundraisingDirectExpenses>17135</FundraisingDirectExpenses>
      <NetIncomeFromFundraisingEvents>
        <TotalRevenueColumn>-2200</TotalRevenueColumn>
        <ExclusionAmount>-2200</ExclusionAmount>
      </NetIncomeFromFundraisingEvents>
      <TotalRevenue>
        <TotalRevenueColumn>3190016</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>0</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>149107</ExclusionAmount>
      </TotalRevenue>
      <GrantsToDomesticOrgs>
        <Total>921000</Total>
        <ProgramServices>921000</ProgramServices>
      </GrantsToDomesticOrgs>
      <CompCurrentOfficersDirectors>
        <Total>89999</Total>
        <ProgramServices>71150</ProgramServices>
        <ManagementAndGeneral>13424</ManagementAndGeneral>
        <Fundraising>5425</Fundraising>
      </CompCurrentOfficersDirectors>
      <OtherSalariesAndWages>
        <Total>21982</Total>
        <ProgramServices>19153</ProgramServices>
        <ManagementAndGeneral>1519</ManagementAndGeneral>
        <Fundraising>1310</Fundraising>
      </OtherSalariesAndWages>
      <PayrollTaxes>
        <Total>9166</Total>
        <ProgramServices>7487</ProgramServices>
        <ManagementAndGeneral>1133</ManagementAndGeneral>
        <Fundraising>546</Fundraising>
      </PayrollTaxes>
      <FeesForServicesAccounting>
        <Total>12335</Total>
        <ManagementAndGeneral>9335</ManagementAndGeneral>
        <Fundraising>3000</Fundraising>
      </FeesForServicesAccounting>
      <FeesForServicesInvstMgmntFees>
        <Total>18278</Total>
        <ManagementAndGeneral>18278</ManagementAndGeneral>
      </FeesForServicesInvstMgmntFees>
      <FeesForServicesOther>
        <Total>15818</Total>
        <ProgramServices>14800</ProgramServices>
        <ManagementAndGeneral>943</ManagementAndGeneral>
        <Fundraising>75</Fundraising>
      </FeesForServicesOther>
      <Advertising>
        <Total>10015</Total>
        <ProgramServices>10015</ProgramServices>
      </Advertising>
      <OfficeExpenses>
        <Total>11485</Total>
        <ProgramServices>1759</ProgramServices>
        <ManagementAndGeneral>9433</ManagementAndGeneral>
        <Fundraising>293</Fundraising>
      </OfficeExpenses>
      <InformationTechnology>
        <Total>20713</Total>
        <ProgramServices>19092</ProgramServices>
        <ManagementAndGeneral>211</ManagementAndGeneral>
        <Fundraising>1410</Fundraising>
      </InformationTechnology>
      <Occupancy>
        <Total>18936</Total>
        <ProgramServices>14512</ProgramServices>
        <ManagementAndGeneral>3251</ManagementAndGeneral>
        <Fundraising>1173</Fundraising>
      </Occupancy>
      <ConferencesMeetings>
        <Total>11146</Total>
        <ProgramServices>10969</ProgramServices>
        <ManagementAndGeneral>177</ManagementAndGeneral>
      </ConferencesMeetings>
      <DepreciationDepletion>
        <Total>914</Total>
        <ProgramServices>822</ProgramServices>
        <ManagementAndGeneral>46</ManagementAndGeneral>
        <Fundraising>46</Fundraising>
      </DepreciationDepletion>
      <Insurance>
        <Total>17910</Total>
        <ManagementAndGeneral>17046</ManagementAndGeneral>
        <Fundraising>864</Fundraising>
      </Insurance>
      <OtherExpenses>
        <Description>ADMINISTRATION</Description>
        <Total>44019</Total>
        <ManagementAndGeneral>38974</ManagementAndGeneral>
        <Fundraising>5045</Fundraising>
      </OtherExpenses>
      <OtherExpenses>
        <Description>RECOGNITION</Description>
        <Total>6802</Total>
        <ProgramServices>5691</ProgramServices>
        <ManagementAndGeneral>300</ManagementAndGeneral>
        <Fundraising>811</Fundraising>
      </OtherExpenses>
      <OtherExpenses>
        <Description>DUES AND SUBSCRIPTIONS</Description>
        <Total>1655</Total>
        <ProgramServices>1120</ProgramServices>
        <ManagementAndGeneral>332</ManagementAndGeneral>
        <Fundraising>203</Fundraising>
      </OtherExpenses>
      <TotalFunctionalExpenses>
        <Total>1232173</Total>
        <ProgramServices>1097570</ProgramServices>
        <ManagementAndGeneral>114402</ManagementAndGeneral>
        <Fundraising>20201</Fundraising>
      </TotalFunctionalExpenses>
      <CashNonInterestBearing>
        <BOY>100</BOY>
        <EOY>117</EOY>
      </CashNonInterestBearing>
      <SavingsAndTempCashInvestments>
        <BOY>889799</BOY>
        <EOY>603266</EOY>
      </SavingsAndTempCashInvestments>
      <OtherNotesLoansReceivableNet>
        <BOY>56415</BOY>
        <EOY>56415</EOY>
      </OtherNotesLoansReceivableNet>
      <LandBuildingsEquipmentBasisNet>
        <BOY>913</BOY>
      </LandBuildingsEquipmentBasisNet>
      <InvestmentsPubTradedSecurities>
        <BOY>2184147</BOY>
        <EOY>4996384</EOY>
      </InvestmentsPubTradedSecurities>
      <OtherAssetsTotal>
        <BOY>8014</BOY>
        <EOY>8014</EOY>
      </OtherAssetsTotal>
      <TotalAssets>
        <BOY>3139388</BOY>
        <EOY>5664196</EOY>
      </TotalAssets>
      <AccountsPayableAccruedExpenses>
        <BOY>3841</BOY>
        <EOY>4846</EOY>
      </AccountsPayableAccruedExpenses>
      <TotalLiabilities>
        <BOY>3841</BOY>
        <EOY>4846</EOY>
      </TotalLiabilities>
      <FollowSFAS117>X</FollowSFAS117>
      <UnrestrictedNetAssets>
        <BOY>3125261</BOY>
        <EOY>5649064</EOY>
      </UnrestrictedNetAssets>
      <PermanentlyRestrictedNetAssets>
        <BOY>10286</BOY>
        <EOY>10286</EOY>
      </PermanentlyRestrictedNetAssets>
      <TotalNetAssetsFundBalances>
        <BOY>3135547</BOY>
        <EOY>5659350</EOY>
      </TotalNetAssetsFundBalances>
      <TotalLiabNetAssetsFundBalances>
        <BOY>3139388</BOY>
        <EOY>5664196</EOY>
      </TotalLiabNetAssetsFundBalances>
      <MethodOfAccountingAccrual>X</MethodOfAccountingAccrual>
      <AccountantCompileOrReview>0</AccountantCompileOrReview>
      <FSAudited>1</FSAudited>
      <AuditCommittee>1</AuditCommittee>
      <FinancialStatementSeparate>X</FinancialStatementSeparate>
      <FederalGrantAuditRequired>0</FederalGrantAuditRequired>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PubliclySupportedOrg170b1Avi>X</PubliclySupportedOrg170b1Avi>
      <GiftsGrantsContribReceived170>
        <CurrentTaxYearMinus4Years>737182</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>764514</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>892768</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>2042938</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>3040909</CurrentTaxYear>
        <Total>7478311</Total>
      </GiftsGrantsContribReceived170>
      <Total170>
        <CurrentTaxYearMinus4Years>737182</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>764514</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>892768</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>2042938</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>3040909</CurrentTaxYear>
        <Total>7478311</Total>
      </Total170>
      <AmountsSubstContributorsTotal>1164766</AmountsSubstContributorsTotal>
      <PublicSupportTotal170>6313545</PublicSupportTotal170>
      <GrossInvestmentIncome170>
        <CurrentTaxYearMinus4Years>61694</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>65399</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>74948</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>76205</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>67246</CurrentTaxYear>
        <Total>345492</Total>
      </GrossInvestmentIncome170>
      <NetUBI>
        <CurrentTaxYear>-2200</CurrentTaxYear>
        <Total>-2200</Total>
      </NetUBI>
      <TotalSupport>7821603</TotalSupport>
      <PublicSupportPertcentage170>0.80720</PublicSupportPertcentage170>
      <PublicSupportPertcentPriorYear>0.66090</PublicSupportPertcentPriorYear>
      <ThirtyThreePercntTestsCY170>X</ThirtyThreePercntTestsCY170>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInfo>
        <ContributorNumber>RESTRICTED</ContributorNumber>
        <ContributorNameBusiness>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorNameBusiness>
        <ContributorAddressUS>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorAddressUS>
        <AggregateContributions>RESTRICTED</AggregateContributions>
      </ContributorInfo>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <CurrentYear>
        <BeginningOfYearBalance>131606</BeginningOfYearBalance>
        <Contributions>1922060</Contributions>
        <EndOfYearBalance>2053666</EndOfYearBalance>
      </CurrentYear>
      <CurrentYearMinus1Year>
        <BeginningOfYearBalance>131606</BeginningOfYearBalance>
        <EndOfYearBalance>131606</EndOfYearBalance>
      </CurrentYearMinus1Year>
      <BoardDesignatedEOYBalance>1.00000</BoardDesignatedEOYBalance>
      <EndowmentsHeldByUnrelatedOrgs>0</EndowmentsHeldByUnrelatedOrgs>
      <EndowmentsHeldByRelatedOrgs>0</EndowmentsHeldByRelatedOrgs>
      <TotalOfBookValueLandBuildings>0</TotalOfBookValueLandBuildings>
      <TotalRevenue>3190016</TotalRevenue>
      <TotalExpenses>1232173</TotalExpenses>
      <ExcessOrDeficitForYear>1957843</ExcessOrDeficitForYear>
      <NetUnrealizedGLOnInvestments>565959</NetUnrealizedGLOnInvestments>
      <TotalAdjustments>565959</TotalAdjustments>
      <ExcessOrDeficitPerFS>2523802</ExcessOrDeficitPerFS>
      <TotRevenueEtcAuditedFinclStmt>3755975</TotRevenueEtcAuditedFinclStmt>
      <NetUnrealizedGainsInvestments>565959</NetUnrealizedGainsInvestments>
      <RevenueNotRptdF990>565959</RevenueNotRptdF990>
      <RevenueSubtotal>3190016</RevenueSubtotal>
      <RevenueNotRptdOnFinStmt>0</RevenueNotRptdOnFinStmt>
      <TotalRevenuePerForm990>3190016</TotalRevenuePerForm990>
      <TotExpensesEtcAuditedFinclStmt>1232173</TotExpensesEtcAuditedFinclStmt>
      <ExpensesNotRptdF990>0</ExpensesNotRptdF990>
      <ExpensesSubtotal>1232173</ExpensesSubtotal>
      <ExpensesNotRptdOnFinStmt>0</ExpensesNotRptdOnFinStmt>
      <TotalExpensesPerForm990>1232173</TotalExpensesPerForm990>
      <Form990ScheduleDPartXIV>
        <Identifier>Part V, Line 4:</Identifier>
        <ReturnReference>Description of Intended Use of Endowment Funds:</ReturnReference>
        <Explanation>Established an endowment account in fiscal 2007-08 and only one contribution to date has been designated specifically to the Endowment account. The Board of Directors can and has made the decision to add unrestricted funds to the endowment fund in order to grow this fund so that future income earned may be used for grant awards and organization operations, if necessary. The endowment account is managed by members of the board of directors' Finance Committee.</Explanation>
      </Form990ScheduleDPartXIV>
    </IRS990ScheduleD>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <RecordsMaintained>1</RecordsMaintained>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>Saint Louis University</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>3556 Caroline Mall Rm 120</AddressLine1>
          <City>St Louis</City>
          <State>MO</State>
          <ZIPCode>63104</ZIPCode>
        </AddressUS>
        <AmountOfCashGrant>75000</AmountOfCashGrant>
        <PurposeOfGrant>Research role in adoptively transferring GPI-specific regulatory T cells to treat the effector phase of rheumatoid arthritis.</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>Oklahoma Medical Research Foundation</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>825 NE 13th Street MS 57</AddressLine1>
          <City>Oklahoma City</City>
          <State>OK</State>
          <ZIPCode>73104</ZIPCode>
        </AddressUS>
        <AmountOfCashGrant>75000</AmountOfCashGrant>
        <PurposeOfGrant>Research role in genes for early systemic lupus erythematosus autoimmunity in African Americans.</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>Stanford University Office of Sponsored Research</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>340 Panama Street</AddressLine1>
          <City>Stanford</City>
          <State>CA</State>
          <ZIPCode>94305</ZIPCode>
        </AddressUS>
        <AmountOfCashGrant>60000</AmountOfCashGrant>
        <PurposeOfGrant>Research role in multi-factor knee meniscus tissue engineering.</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>The Scripps Research Institute</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>10550 North Torrey Pines Rd MEM 161</AddressLine1>
          <AddressLine2>161</AddressLine2>
          <City>La Jolla</City>
          <State>CA</State>
          <ZIPCode>92037</ZIPCode>
        </AddressUS>
        <AmountOfCashGrant>75000</AmountOfCashGrant>
        <PurposeOfGrant>Research role of cartilage-specfic microRNA in osteoarthritis pathogensis.</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>Children's Hospital Boston</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>Smith 516C One Jimmy Fund Way</AddressLine1>
          <City>Boston</City>
          <State>MA</State>
          <ZIPCode>02115</ZIPCode>
        </AddressUS>
        <AmountOfCashGrant>75000</AmountOfCashGrant>
        <PurposeOfGrant>Research role in a novel modulator of neutrophil function in inflammatory arthritis.</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>University of Arizona</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>1501 N Campbell Ave</AddressLine1>
          <City>Tuscon</City>
          <State>AZ</State>
          <ZIPCode>85724</ZIPCode>
        </AddressUS>
        <AmountOfCashGrant>75000</AmountOfCashGrant>
        <PurposeOfGrant>Research role in the characterization of pathogenic Th17 responses in collagen induced arthritis.</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UCLA</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>Div of Rehumatology 1000 Veteran</AddressLine1>
          <AddressLine2>Ave Rehab Ctr 32-59</AddressLine2>
          <City>Los Angeles</City>
          <State>CA</State>
          <ZIPCode>900951670</ZIPCode>
        </AddressUS>
        <AmountOfCashGrant>75000</AmountOfCashGrant>
        <PurposeOfGrant>Research role in the programmed deat-1-prgramed death-1-ligand pathway in the New Zealand Black x New Zealand white murine model: a molecular approach.</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>New York University School of Medicine</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>540 First Avenue SKI 2-17</AddressLine1>
          <City>New York</City>
          <State>NY</State>
          <ZIPCode>10016</ZIPCode>
        </AddressUS>
        <AmountOfCashGrant>75000</AmountOfCashGrant>
        <PurposeOfGrant>Research of the roles of IL-23 and IL-22 in arthritogenic Th17 cell responses and the pathogensis of autoimmune arthritis.</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>Stanford University</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>301 Ravenswood Avenue</AddressLine1>
          <City>Menlo Park</City>
          <State>CA</State>
          <ZIPCode>94025</ZIPCode>
        </AddressUS>
        <AmountOfCashGrant>75000</AmountOfCashGrant>
        <PurposeOfGrant>Research role in new humanized mouse model of chronic rheumatoid arthritis in humans</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UCLA</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>Div of Rehumatology 1000 Veteran</AddressLine1>
          <AddressLine2>Ave Rehab Ctr 32-59</AddressLine2>
          <City>Los Angeles</City>
          <State>CA</State>
          <ZIPCode>900951670</ZIPCode>
        </AddressUS>
        <AmountOfCashGrant>75000</AmountOfCashGrant>
        <PurposeOfGrant>Research role in the influence of leptin on regulatory T cells in murine lupus</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>University of Chicago</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>970 E 58th Street</AddressLine1>
          <City>Chicago</City>
          <State>IL</State>
          <ZIPCode>60637</ZIPCode>
        </AddressUS>
        <AmountOfCashGrant>75000</AmountOfCashGrant>
        <PurposeOfGrant>Research role in the genetic regulation of interferon alpha human lupus.</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>Brigham &amp; Women's Hospital Harvard Medical School</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>Smith Building Room 536 1 Jimmy</AddressLine1>
          <AddressLine2>Fund Way</AddressLine2>
          <City>Boston</City>
          <State>MA</State>
          <ZIPCode>02115</ZIPCode>
        </AddressUS>
        <AmountOfCashGrant>75000</AmountOfCashGrant>
        <PurposeOfGrant>Research role in the mechanisms of LTB4-induced migration and invasion in fibroblast-like synoviocytes (FLS)</PurposeOfGrant>
      </RecipientTable>
      <TotalNbrOf501C3AndGovtGrants>12</TotalNbrOf501C3AndGovtGrants>
      <TotalNbrOfOtherOrganizations>0</TotalNbrOfOtherOrganizations>
      <Form990ScheduleIPartIV>
        <Identifier>Procedure for Monitoring Grants in the U.S.:</Identifier>
        <ReturnReference>Part I, Line 2:</ReturnReference>
        <Explanation>Schedule I, Part I, Line 2: In mid-January each year, the ANRF office receives grant applications from scientists across the country, approximately 60-70 per year. These applications must follow the published Grant Guidelines and Policies established by ANRF. The Scientific Advisory Board (SAB) conducts an NIH-level review process prior to a review meeting session held in March or April (the date varies from year to year, depending on the schedules of the members). At this review meeting, the SAB arrives at a ranking for the applicants. This ranking is presented at the regular board of directors meeting, generally held within a couple weeks of the SAB review meeting. At this board meeting, members review and vote on the annual budget, including the total of grant awards for the year, based on the ranking and recommendations from the SAB. ANRF's largest annual expense is the cumulative total of research grant awards. Grants are paid in two installments (50% each installment) over the course of the fiscal year. The first payment occurs on or before June 1 when a check for 50% of the award is sent to the scientist's research institution. The second payment occurs in early March of the following year once ANRF has received a progress report which is approved by the chair of the Scientific Advisory Board. This progress report must demonstrate adherence to the specific aims outlined in the original proposal and progress toward the goal. At the end of the grant award term, recipients must submit a narrative, final report, in which they delineate their research results and any publications or public presentations (generally at professional scientific meetings) they have generated as a result of the ANRF grant award.</Explanation>
      </Form990ScheduleIPartIV>
    </IRS990ScheduleI>
    <IRS990ScheduleM documentId="RetDoc1042900001">
      <SecuritiesPubliclyTraded>
        <NonCashCheckbox>X</NonCashCheckbox>
        <NumberOfContributions>1</NumberOfContributions>
        <NoncashContribsRptdF990>264872</NoncashContribsRptdF990>
        <MethodOfDeterminingRevenues>Fair Market Value</MethodOfDeterminingRevenues>
      </SecuritiesPubliclyTraded>
      <AnyPropertyThatMustBeHeld>0</AnyPropertyThatMustBeHeld>
      <ReviewProcessUnusualNCGifts>1</ReviewProcessUnusualNCGifts>
      <ThirdPartiesUsed>0</ThirdPartiesUsed>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <GeneralExplanation>
        <Identifier>Form 990, Part VI, Section B, line 11</Identifier>
        <Explanation>Both the audited financial statements and Form 990 are distributed to the members of the board for review. Upon approval by the Board of Directors the executive director signs and releases these documents to the public and/or submits the documents to the internal revenue service.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>Form 990, Part VI, Section B, line 12c</Identifier>
        <Explanation>conflicts of interest are monitored constantly through an annual written confirmation which is completed and submitted by all members of the board of directors. Additionally any possible indication of conflict of interests which are brought to the attention of the board, board members, SAB members or the executive director are examined to determine whether or not a conflict of interest exists. The organization is vigilant in its policy to not have any hint of favortism or conflict of interest. Questions of conflict of interest are placed before the board at meetings and reviewed prior to the meeting discussion by ANRF's legal counsel.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>Form 990, Part VI, Section B, line 15</Identifier>
        <Explanation>Finance Committee uses current surveys of executive compensation and other Form 990s to assist in determining compensation. Actual compensation received is subject to approval by the board of directors and/or the compensation committee. The executive director is not present during these discussions and approval meetings.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>Form 990, Part VI, Section C, line 19</Identifier>
        <Explanation>All requests for the 990, Form 1023, and organizational documents such as financial statements, conflicts of interest policy, and governing documents will be sent out by request via regular mail or e-mail.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>Form 990, Part XI, Line 2C</Identifier>
        <Explanation>The Finance Committee of the Board of Directors has oversight and responsibility for all financial matters pertaining to ANRF. This committee reviews all investments, bank statements, and internal financial statements on a monthly basis. Current snapshot of financial statements and investment accounts are reviewed with the board at meetings (six times a year), the audited financials and Form 990 are reviewed once a year. The budget planning process and investment policy review and updates are also the responsibility of this Committee.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>Form 990, Part VI, Section B</Identifier>
        <ReturnReference>Policies</ReturnReference>
        <Explanation>No whistleblower policy or document retention and destruction policy was in place in the year ending 3/31/10. As of 8/10/10, those policies have been adopted and are being implemented by the organization. This will apply to the fiscal year ending 3/31/11.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>Form 990, Part VII</Identifier>
        <ReturnReference>Board of Directors</ReturnReference>
        <Explanation>Helene Belisle is both the top management and top financial officer within the organization.</Explanation>
      </GeneralExplanation>
    </IRS990ScheduleO>
  </ReturnData>
</Return>